Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-26-031740
Filing Date
2026-08-07
Accepted
2026-08-06 20:24:53
Documents
19
Reference 429
333-276462

Document Format Files

Seq Description Document Type Size
1 S-3 ny20079592x1_s3.htm S-3 604370
2 EXHIBIT 1.2 ny20079592x1_ex1-2.htm EX-1.2 281284
3 EXHIBIT 4.2 ny20079592x1_ex4-2.htm EX-4.2 338499
4 EXHIBIT 5.1 ny20079592x1_ex5-1.htm EX-5.1 44620
5 EXHIBIT 5.2 ny20079592x1_ex5-2.htm EX-5.2 14354
6 EXHIBIT 23.1 ny20079592x1_ex23-1.htm EX-23.1 2034
7 FILING FEES TABLE ny20079592x1_ex107.htm   iXBRL EX-FILING FEES 63047
8 logo_opusgenetics.jpg GRAPHIC 45738
9 logo_opusgeneticsx1.jpg GRAPHIC 40782
10 ny20079592x1_ex5logo.jpg GRAPHIC 2268
  Complete submission text file 0001140361-26-031740.txt   1647852

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT ny20079592x1_ex107_htm.xml XML 17970
Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713 (984) 884-6030
Opus Genetics, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-298100 | Film No.: 261251041
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)